October 16, 2026 Experience Medtronic splits off MiniMed This transaction completes Medtronic’s separation of its diabetes unit
September 30, 2026 Experience Immix Biopharma $125 million stock offering We advised the book-running manager on the offering
September 24, 2026 Experience InnovAge $92.5 million secondary offering We advised the underwriters on the offering
September 23, 2026 Experience Smith+Nephew $700 million notes offering and concurrent tender offer We advised Smith+Nephew on the offering
September 8, 2026 Experience Thyme Companies $125 million Series E financing We advised Morgan Health as lead investor on the financing
September 1, 2026 Experience Coherus Oncology $50 million at-the-market offering We advised the sales agent on the offering
September 1, 2026 Experience Moderna $3 billion convertible notes offering and capped call transactions We advised the initial purchasers on the offering
August 31, 2026 Experience Jazz Pharmaceuticals $1.25 billion exchangeable senior notes offering We advised the initial purchasers on the offering
August 27, 2026 Experience JATT III Acquisition Corp $69 million SPAC IPO We advised the sole bookrunning manager on the IPO
August 26, 2026 Experience Immatics $172.5 million follow-on offering We advised Immatics on the offering